Proteolytic degradation of the accumulated SYN (PD and DLB) or TPPP (MSA) along with their pathological partner, TPPP or SYN, respectively, should then reduce the levels of these proteins and hence reduce the levels of the pathological assemblies (or eliminate them entirely). Here, TPPP is linked to Parkinson disease.